Amgen's Blincyto Data Send Cullinan Higher
WHO Picks JN.1 Variant for Next Set of COVID Vaccines
Gilead Sciences First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Eliminates hundreds of treatments! Pfizer (PFE.US) gene therapy approved for listing by FDA
Pfizer/PFE.us (Pfizer/PFE.us) announced that the US FDA has approved the single-use gene therapy Beqvez (fidanacogene elaparvovec) it has developed to treat adults with moderate to severe hemophilia B aged 18 or above.
AstraZeneca PLC (LON:AZN) Beat Earnings, And Analysts Have Been Reviewing Their Forecasts
Analysts Are Neutral on These Healthcare Stocks: Edwards Lifesciences (EW), Gilead Sciences (GILD)
loading...
wantqq123 : how to get the last chart?
crazypeter1019 : wow congrats bro! I wish I could have the moomoo mug too
JamesimOP wantqq123: Hi, check this.
JamesimOP crazypeter1019: Can. No problem. Keep clambing.
wantqq123 JamesimOP: wa, thanks
View more comments...